102 related articles for article (PubMed ID: 1770046)
1. Clinical significance of urinary laminin P1 in diabetic patients.
Nakajima C; Shimojo N; Naka K; Okuda K; Yamamoto M; Fujii S
J Diabet Complications; 1991; 5(2-3):197-8. PubMed ID: 1770046
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
3. Urinary laminin P1 as an index of glycemic control in children with insulin-dependent diabetes mellitus.
Miyake H; Nagashima K; Yagi H; Onigata K
Diabetes Res; 1993; 23(3):131-8. PubMed ID: 7536137
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of laminin P1 in diabetics with advanced nephropathy.
Pietschmann P; Schernthaner G; Schnack CH; Gaube S
J Clin Pathol; 1988 Sep; 41(9):929-32. PubMed ID: 3192751
[TBL] [Abstract][Full Text] [Related]
5. Elevated N-acetyl-β-d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.
Lee M; Hong N; Lee YH; Kang ES; Cha BS; Lee BW
J Diabetes Complications; 2018 Aug; 32(8):777-783. PubMed ID: 29980431
[TBL] [Abstract][Full Text] [Related]
6. Assay of laminin fragments in the assessment of renal disease.
Price RG; Taylor SA; Crutcher E
Kidney Int Suppl; 1994 Nov; 47():S25-8. PubMed ID: 7869667
[No Abstract] [Full Text] [Related]
7. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions.
Nerlich A; Schleicher E
Am J Pathol; 1991 Oct; 139(4):889-99. PubMed ID: 1928305
[TBL] [Abstract][Full Text] [Related]
8. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of urinary enzymes in diabetic nephropathy.
Morita E; Kaizu K; Uriu K; Hashimoto O; Komine N; Eto S
J Diabet Complications; 1991; 5(2-3):158-9. PubMed ID: 1685160
[TBL] [Abstract][Full Text] [Related]
10. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
Suzuki T; Igari Y; Oba K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():586-91. PubMed ID: 12355814
[No Abstract] [Full Text] [Related]
11. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
Hirai M; Nakano H; Oba K; Metori S
Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
[TBL] [Abstract][Full Text] [Related]
12. The assay of laminin fragments in serum and urine as an indicator of renal damage induced by toxins.
Price RG; Taylor SA; Crutcher E; Bergamaschi E; Franchini I; Mackie AD
Toxicol Lett; 1995 May; 77(1-3):313-8. PubMed ID: 7618157
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of microtransferrinuria in diabetic patients].
Zhou Y; Zhang X; Wu J
Zhonghua Nei Ke Za Zhi; 1997 Mar; 36(3):165-8. PubMed ID: 10374308
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases.
Setty S; Michael AA; Fish AJ; Michael Mauer S; Butkowski RJ; Virtanen I; Kim Y
Mod Pathol; 2012 Jun; 25(6):859-68. PubMed ID: 22343787
[TBL] [Abstract][Full Text] [Related]
15. Markers of diabetic nephropathy.
Hong CY; Chia KS
J Diabetes Complications; 1998; 12(1):43-60. PubMed ID: 9442815
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase].
Nakamura S
Hokkaido Igaku Zasshi; 1991 Jul; 66(4):522-33. PubMed ID: 1680783
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
18. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
Hayashi Y; Makino H; Ota Z
Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
[TBL] [Abstract][Full Text] [Related]
19. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
[TBL] [Abstract][Full Text] [Related]
20. Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.
Lapsley M; Flynn FV; Sansom PA
J Clin Pathol; 1993 May; 46(5):465-9. PubMed ID: 8320329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
